Skip to main content

Table 1 Summary of participant demographic and clinical information

From: Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

 

PD

Control

Cases

225

133

Age (year)a

61.01 ± 10.68

60.0 ± 9.10

Sex (Male:Female)

118:107

68:65

UPDRS IIIa

20.95 ± 11.44

–

Disease duration (year)a

6.28 ± 5.00

–

MoCAa

21.76 ± 5.12

–

  1. a Data shown are mean ± S. D. MoCA Montreal cognitive assessment, PD Parkinson’s disease, UPDRS III Unified Parkinson disease rating scale, part III
Back to article page

Translational Neurodegeneration

ISSN: 2047-9158

Contact us